Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Orphanet Journal of Rare Diseases|April 8, 2021
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in ItalyLorenza Magliano, Laura Obici, Claudia Sforzini, et al.Translational Neurodegeneration|July 28, 2022
Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson's diseaseMatilde Bongianni, Mauro Catalan, Daniela Perra, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 2, 2023
Use, tolerability, benefits and side effects of orthotic devices in Charcot-Marie-Tooth diseaseAlessandro Bertini, Fiore Manganelli, Gian Maria Fabrizi, et al.Brain Communications|April 19, 2021
Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodiesDaniela Perra, Matilde Bongianni, Giovanni Novi, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 15, 2024
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in ItalyLuca Gentile, Anna Mazzeo, Chiara Briani, et al.European Journal of Neurology|March 31, 2023
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathiesPietro Emiliano Doneddu, Chiara Briani, Dario Cocito, et al.Journal of Neurology|February 15, 2025
Patisiran in ATTRv amyloidosis with polyneuropathy: "PatisiranItaly" multicenter observational studyVincenzo Di Stefano, Pietro Guaraldi, Angela Romano, et al.European Journal of Neurology|June 2, 2026
Deep Phenotyping of F64L Mutation in a Multicentric Cohort of Patisiran-Treated Hereditary Transthyretin Amyloidosis Patients (Patisiranitaly)Marco Ceccanti, Pietro Guaraldi, Angela Romano, et al.Pageof 3